Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
Funds clinical trials testing whether a product works and is safe for a rare disease, aimed at a new indication or a labeling change.
Most rare diseases have no approved treatment, and the ones that do often got there through a small, hard-won trial rather than a large one. This notice funds that trial.
The money supports clinical trials evaluating a product's efficacy and safety in support of a new indication or a labeling change for a rare disease or condition. FDA names the goal directly: more approved treatments for rare di…
Clinical trials evaluating the efficacy and/or safety of a product for a rare disease or condition, in support of a new indication or a labeling change, favouring collaborative, efficient or innovative trial designs. A clinical trial is required under this activity code.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up